Evidence map›Paper›PMID 33935397›Full record

ArticleVeterinary world2021

The vulnerary potential of botanical medicines in the treatment of bacterial pathologies in fish.

Farida Nurzhanova, Gaisa Absatirov, Bekzhasar Sidikhov, Alexander Sidorchuk, Nurbek Ginayatov, Kenzhebek Murzabaev

Open access · goldAbstract read
In one paragraph

Article in Veterinary world, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Molecular and Pharmacokinetic Rationale for the Use ofMolecules (Basel, Switzerland) · 2026
    Article
  3. Unveiling the Potential of CuO and CuNanomaterials (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Farida NurzhanovaZhangir Khan West Kazakhstan Agrarian-Technical University, Republic of Kazakhstan.
Gaisa AbsatirovZhangir Khan West Kazakhstan Agrarian-Technical University, Republic of Kazakhstan.
Bekzhasar SidikhovZhangir Khan West Kazakhstan Agrarian-Technical University, Republic of Kazakhstan.
Alexander SidorchukMoscow State Academy of Veterinary Medicine and Biotechnology named after K.I. Skryabin, Russia.
Nurbek GinayatovZhangir Khan West Kazakhstan Agrarian-Technical University, Republic of Kazakhstan.
Kenzhebek MurzabaevZhangir Khan West Kazakhstan Agrarian-Technical University, Republic of Kazakhstan.
Zhangir Khan West Kazakhstan Agrarian Technical University · KZMoscow State Academy of Veterinary Medicine and Biotechnology named after Skryabin · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimThe use of plant-based medicine in treating and preventing fish disease has become increasingly popular due to the resistance of bacterial pathogens to chemicals widely used in aquaculture. This study explored the vulnerary effect of botanical medicines made from local raw materials (greater celandine [ MATERIALS AND

methodsThe vulnerary activity of herbal infusions was studied on spontaneously infected fish by assessing the degree of wound healing at regular intervals: The state of the wound, reduction of the wound surface area, the formation of granulation tissue, epithelization, and wound contraction.

resultsA positive vulnerary effect of

conclusionPractical use and the results of this study show the potential of using herbal infusions for therapeutic purposes in aquaculture.

Indexed as

fishplant raw materialvulnerary effectwound

Identifiers

PMID33935397
PMCPMC8076460
OpenAlexW3133615184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.